Multimodal Imaging of Blood–Brain Barrier Dysfunction in Parkinson's Disease: From Pathological Mechanisms to Therapeutic Opportunities
European Journal of Neuroscience · 2025-09 · 62 (5)
DOI: 10.1111/ejn.70237 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift European Journal of Neuroscience, 2025-09. Verfasst von Zihao Lu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, Huaxi MR Research Center (HMRRC), Institute of Radiology and Medical Imaging, West China Hospital of Sichuan University, Che…. Hauptthemen laut MEDLINE: Blood-Brain Barrier, Parkinson Disease, Multimodal Imaging. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 263 Literaturangaben. Gefördert von: National Key R&D Program of China, National Natural Science Foundation of China, National Key Research and Development Program of China.
Abstract (Originalsprache)
In Parkinson's disease (PD), blood–brain barrier (BBB) dysfunction is shifting from being viewed as a passive marker of damage to a key pathological driver and potential therapeutic target. Its disruption involves mechanisms such as abnormal α‐synuclein transport, tight junction breakdown, inflammatory activation, and vascular remodeling, all of which significantly disturb the neural microenvironment. Imaging technologies are playing an increasingly pivotal role in unraveling these complex processes. Based on current clinical and experimental evidence, this review outlines the major mechanisms of BBB disruption in PD and focuses on recent advances in multiscale imaging techniques for BBB research. It covers super‐resolution microscopy, two‐photon imaging, MRI, and PET, emphasizing their critical value in mechanistic investigation, functional assessment, and target localization. Multimodal imaging enables cross‐scale integration—from nanoscopic to macroscopic levels and from laboratory research to clinical application—and holds promise for building a “mechanism–imaging–intervention” framework that may accelerate the translation from pathophysiological understanding to clinical intervention.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Radiology, Huaxi MR Research Center (HMRRC), Institute of Radiology and Medical Imaging, West China Hospital of Sichuan University, Chengdu, Sichuan, China.
- Psychoradiology Key Laboratory of Sichuan Province, West China Hospital of Sichuan University, Chengdu, Sichuan, China.
- Department of Machine Design & Manufacturing and Automation, School of Mechanical Engineering, Sichuan University, Chengdu, China.
- Research Unit of Psychoradiology, Chinese Academy of Medical Sciences, Chengdu, Sichuan, China.
- Xiamen Key Lab of Psychoradiology and Neuromodulation, Department of Radiology, West China Xiamen Hospital of Sichuan University, Xiamen, Fujian, China.
ORCID-Profile: Qiyong Gong
Förderung
- National Key R&D Program of China
- National Natural Science Foundation of China
- National Key Research and Development Program of China
Zitieren
APA
Lu, Z., Yin, H., Xiang, P., Yi, X., Tian, X., & Gong, Q. (2025). Multimodal Imaging of Blood–Brain Barrier Dysfunction in Parkinson's Disease: From Pathological Mechanisms to Therapeutic Opportunities. European Journal of Neuroscience, 62(5). https://doi.org/10.1111/ejn.70237
Vancouver
Lu Z, Yin H, Xiang P, Yi X, Tian X, Gong Q. Multimodal Imaging of Blood–Brain Barrier Dysfunction in Parkinson's Disease: From Pathological Mechanisms to Therapeutic Opportunities. European Journal of Neuroscience. 2025;62(5). doi:10.1111/ejn.70237
BibTeX
@article{Lu2025,
author = {Lu, Zihao and Yin, Haolin and Xiang, Pan and Yi, Xuan and Tian, Xiaohe and Gong, Qiyong},
title = {Multimodal Imaging of Blood–Brain Barrier Dysfunction in Parkinson's Disease: From Pathological Mechanisms to Therapeutic Opportunities},
journal = {European Journal of Neuroscience},
year = {2025},
volume = {62},
number = {5},
doi = {10.1111/ejn.70237}
}
EUVIMED